Quantcast

Latest Chronic obstructive pulmonary disease Stories

2014-04-30 12:30:17

- First results of the pivotal Phase 3 INPULSIS(TM) trials investigating the efficacy and safety of nintedanib, an investigational compound, in the treatment of idiopathic pulmonary fibrosis (IPF) RIDGEFIELD, Conn., April 30, 2014 /PRNewswire/ -- Boehringer Ingelheim announced today that the first results from two highly anticipated Phase 3 trials in idiopathic pulmonary fibrosis (IPF) and in chronic obstructive pulmonary disease (COPD) will be presented at the 2014 American...

2014-04-28 08:32:52

RESEARCH TRIANGLE PARK, N.C. and SOUTH SAN FRANCISCO, Calif., April 28, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that Anoro(TM) Ellipta(®) (umeclidinium and vilanterol inhalation powder), the first once-daily product approved in the US that combines two long-acting bronchodilators in a single inhaler for the maintenance treatment of chronic obstructive pulmonary disease (COPD), is now available to retail pharmacies...

2014-04-24 23:04:03

Lung Institute Provides Lung Disease Sufferers Advice to Avoid a Flare-Up During Allergy Season (PRWEB) April 24, 2014 To the majority of the population, pollen season is just an annual inconvenience that can be pacified by a simple trip to the doctor and a pack of tissues. But for individuals with chronic obstructive pulmonary disease (COPD), the third leading cause of death in the United States, allergy season means an increase in the likelihood of an exacerbation, also known as a...

2014-04-24 23:02:54

American Lung Association in Washington & Aljoya Thornton Place Hold Respiratory Rally to Educate Residents, Friends & Neighbors about Caring for Those with Respiratory Challenges. Seattle (PRWEB) April 24, 2014 Respiratory conditions are so common and wide reaching that nearly all of us are affected by one or more in our lifetime. As with many conditions, seniors and children are especially vulnerable to respiratory illness. On Saturday, May 3rd from 10 a.m. - 3 p.m., the...

2014-04-24 12:28:48

Each of the Emerging LABA/LAMA Fixed-Dose Combinations Has Advantages Over Current Therapies on Efficacy Measures, According to Findings from Decision Resources Group BURLINGTON, Mass., April 24, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. and European pulmonologists agree that a therapy offering a greater reduction in exacerbations is among the areas of greatest opportunity for chronic obstructive pulmonary disease (COPD) treatments. The majority of surveyed U.S....

2014-04-23 23:08:57

For the fourth consecutive year, Austin-based Alen Corporation will have a significant presence at the American Lung Association’s (ALA) Fight for Air Climb, taking place April 26 at the Frost Bank Tower in downtown Austin, Texas. Alen, an air purifier company, says its involvement is just one way that it is working to bring awareness to the health issues associated with poor indoor air quality. Austin, TX (PRWEB) April 23, 2014 The Fight for Air Climb’s purpose is to call attention...

2014-04-23 23:04:20

New research report “COPD Drug Market Opportunity & Clinical Pipeline Analysis” worked out by Kuick Research is now available at MarketPublishers.com. According to the study, the world COPD market is predicted to grow at a CAGR of nearly 8% and reach USD 17.5 billion by 2018. London, UK (PRWEB) April 23, 2014 Around 1 billion people across the globe suffer from pulmonary or respiratory diseases. Within the respiratory therapeutic domain, chronic obstructive pulmonary disease...

2014-04-19 04:20:44

DALLAS, April 19, 2014 /PRNewswire/ -- ReportsnReports.com offers COPD Drug Market Opportunity & Clinical Pipeline Analysis 2014 to 2018 industry research report in its store at http://www.reportsnreports.com/reports/280894-copd-drug-market-opportunity-clinical-pipeline-analysis.html . The global market for COPD has been estimated to be close to US$ 12 billion in 2013. With a high number of new and more efficient and convenient drugs crowding the market, it is...

2014-04-17 15:25:19

Findings were consistent even after taking into account the severity of the person's illness A group of drugs commonly prescribed for insomnia, anxiety and breathing issues "significantly increase the risk" that older people with chronic obstructive pulmonary disease, or COPD, need to visit a doctor or Emergency Department for respiratory reasons, new research has found. Benzodiazepines, such as Ativan or Xanax, may actually contribute to respiratory problems, such as depressing...

2014-04-17 08:27:44

Potential to Provide Needed Breathing Support for Patients with Neuromuscular Diseases and Non-Oxygen Dependent Respiratory Diseases IRVINE, Calif., April 17, 2014 /PRNewswire/ -- Breathe Technologies, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the fifth 510(k) clearance for its Non-Invasive Open Ventilation (NIOV) System, allowing its use with compressed air supply for non-oxygen dependent patients. The previous four FDA clearances cover the...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related